Thus, Chen et al. have carried out a quantitative detection of Apolipoprotein A-II (APOA2 protein) in the urine, the former being a biomarker for bladder cancer diagnosis, with the use of a n-type polycrystalline silicon field-effect transistor. Here, APOA2 is linked to urinary bladder carcinoma.